Rchr
J-GLOBAL ID：201901001658128061   Update date: May. 17, 2024

Miho Riku

Miho Riku
Research theme for competitive and other funds  (2)：
  • 2020 - 2023 乳癌の新規予後規定因子TSHZ2によるクロマチン制御と上皮間葉転換調節機構の解明
  • 2016 - 2018 新規転写抑制因子TSHZ2によるクロマチン制御を介した乳癌進展機構の解明
Papers (19)：
  • Sivasundaram Karnan, Akinobu Ota, Hideki Murakami, Md. Lutfur Rahman, Md Wahiduzzaman, Muhammad Nazmul Hasan, Lam Quang Vu, Ichiro Hanamura, Akihito Inoko, Miho Riku, et al. CAMK2D: a novel molecular target for BAP1-deficient malignant mesothelioma. Cell Death Discovery. 2023
  • Yuichi Riku, Yasushi Iwasaki, Shinsuke Ishigaki, Akio Akagi, Masato Hasegawa, Kenya Nishioka, Yuanzhe Li, Miho Riku, Takeshi Ikeuchi, Yusuke Fujioka, et al. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration. Brain : a journal of neurology. 2022. 145. 8. 2769-2784
  • Takumi Tsunoda, Miho Riku, Norika Yamada, Hikaru Tsuchiya, Takuya Tomita, Minako Suzuki, Mari Kizuki, Akihito Inoko, Hideaki Ito, Kenta Murotani, et al. ENTREP/FAM189A2 encodes a new ITCH ubiquitin ligase activator that is downregulated in breast cancer. EMBO reports. 2022. 23. 2. e51182
  • 陸 美穂, 村上 秀樹, 小野 謙三, 横山 多佳子, 加藤 宗博, 笠井 謙次. ラブドイド形質を伴う肉腫型悪性中皮腫の一剖検例. 現代医学. 2021. 68. 1. 123-128
  • Akane Sugimura-Nagata, Akira Koshino, Satoshi Inoue, Aya Matsuo-Nagano, Masayuki Komura, Miho Riku, Hideaki Ito, Akihito Inoko, Hideki Murakami, Masahide Ebi, et al. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer. International Journal of Molecular Sciences. 2021. 22. 5. 2690-2690
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM